ArticleBMC cancer2022

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria.

Christine Deutschmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.